VEGFA and leukemia: So, the scenario of a continuous metabolic loop, in which VEGF acts on VEGFR2 to activate PI3K/Akt/mTOR pathway that will induce the expression of both MCT1, driving the metabolic fitness, and VEGF that will perpetuate the metabolic adaptation of leukemia cells, can be a possibility.